Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Comment on “Nonhematopoietic Cells Are Key Players in Innate Control of Bacterial Airway Infection”

Samithamby Jeyaseelan
J Immunol May 1, 2011, 186 (9) 5019; DOI: https://doi.org/10.4049/jimmunol.1190013
Samithamby Jeyaseelan
Department of Pathobiological Sciences, Louisiana State University, Baton Rouge, LA 70803
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Using bone marrow chimeras, LeibundGut-Landmann et al. conclude in a recent study that nonhematopoietic cells are important to host defense in the lung against an intracellular pathogen, Legionella pneumophila (reviewed in Ref. 1). Neutrophils are a critical contributor to host defense in the lungs (2) because selective depletion of neutrophils results in substantial reduction in the clearance of Klebsiella pneumoniae and L. pneumophila organisms. Using bone marrow chimeras, we have shown that both hematopoietic and nonhematopoietic cells in the lungs are essential for neutrophil-dependent host defense against extracellular pathogens, including Escherichia coli (3) and K. pneumoniae (4). CXCL1/KC, CXCL2/MIP-2, CXCL5/LIX, and lungkine are the primary neutrophil chemokines in mice, and the receptor for these chemokines, CXCR2, is expressed on both hematopoietic and nonhematopoietic cells. KC and MIP-2 are produced by both hematopoietic and nonhematopoietic cells in the lung (2), whereas LIX and lungkine are secreted primarily by nonhematopoietic cells, such as epithelial cells (5, 6). Although the reported findings (1) are conclusive, neutrophil accumulation was measured within 28 h following infection and epithelial chemokines have not been measured. Nonetheless, these findings (1) lead us to wonder whether both hematopoietic and nonhematopoietic cells are important for neutrophil-dependent host defense to extracellular Gram-negative pathogens, or whether one of these cell types is necessary and/or sufficient to induce host defense against intracellular Gram-negative pathogens. These findings will have translational implications for harnessing innate immunity versus targeting the causative bacterium to combat multidrug-resistant bacteria and to develop potent vaccines against pulmonary infections.

  • Copyright © 2011 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. LeibundGut-Landmann S.,
    2. K. Weidner,
    3. H. Hilbi,
    4. A. Oxenius
    . 2011. Nonhematopoietic cells are key players in innate control of bacterial airway infection. J. Immunol.186: 3130–3137.
    OpenUrl
  2. ↵
    1. Balamayooran G.,
    2. S. Batra,
    3. M. B. Fessler,
    4. K. I. Happel,
    5. S. Jeyaseelan
    . 2010. Mechanisms of neutrophil accumulation in the lungs against bacteria. Am. J. Respir. Cell Mol. Biol.43: 5–16.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Cai S.,
    2. R. L. Zemans,
    3. S. K. Young,
    4. G. S. Worthen,
    5. S. Jeyaseelan
    . 2009. Myeloid differentiation protein-2-dependent and -independent neutrophil accumulation during Escherichia coli pneumonia. Am. J. Respir. Cell Mol. Biol.40: 701–709.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Cai S.,
    2. S. Batra,
    3. S. A. Lira,
    4. J. K. Kolls,
    5. S. Jeyaseelan
    . 2010. CXCL1 regulates pulmonary host defense to Klebsiella infection via CXCL2, CXCL5, NF-kappaB, and MAPKs. J. Immunol.185: 6214–6225.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Jeyaseelan S.,
    2. R. Manzer,
    3. S. K. Young,
    4. M. Yamamoto,
    5. S. Akira,
    6. R. J. Mason,
    7. G. S. Worthen
    . 2005. Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am. J. Respir. Cell Mol. Biol.32: 531–539.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Rossi D. L.,
    2. S. D. Hurst,
    3. Y. Xu,
    4. W. Wang,
    5. S. Menon,
    6. R. L. Coffman,
    7. A. Zlotnik
    . 1999. Lungkine, a novel CXC chemokine, specifically expressed by lung bronchoepithelial cells. J. Immunol.162: 5490–5497.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 186 (9)
The Journal of Immunology
Vol. 186, Issue 9
1 May 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comment on “Nonhematopoietic Cells Are Key Players in Innate Control of Bacterial Airway Infection”
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comment on “Nonhematopoietic Cells Are Key Players in Innate Control of Bacterial Airway Infection”
Samithamby Jeyaseelan
The Journal of Immunology May 1, 2011, 186 (9) 5019; DOI: 10.4049/jimmunol.1190013

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comment on “Nonhematopoietic Cells Are Key Players in Innate Control of Bacterial Airway Infection”
Samithamby Jeyaseelan
The Journal of Immunology May 1, 2011, 186 (9) 5019; DOI: 10.4049/jimmunol.1190013
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Response to Comment on “Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines”
  • Comment on “Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines”
  • Response to Comment on “Mice Lacking the Purinergic Receptor P2X5 Exhibit Defective Inflammasome Activation and Early Susceptibility to Listeria monocytogenes”
Show more LETTERS TO THE EDITOR

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606